No products in the cart.
Mounjaro Tirzepatide Injection wholesale – supplier (manufacturer)
$2.00
Tirzepatide Injection Mounjaro provides 5mg of tirzepatide in a 0.5ml pre-filled pen format. Each box contains 4 pens. Manufactured by Eli Lilly and Company. NMPA HJ20240023. For research use only. Supports wholesale and retail.?For wholesale prices, other specifications and uses, please consult our staff?
Description
Mounjaro Tirzepatide is a dual GIP and GLP-1 receptor agonist, developed to regulate glucose metabolism and body weight. It is a novel peptide used in metabolic research, including models of obesity, type 2 diabetes, and insulin resistance.
This research-grade product delivers 5mg of tirzepatide in 0.5ml, supplied as 4 pre-filled injection pens per box. It is widely used in endocrinological and pharmacological research, especially in GLP-1 receptor studies.
Manufactured by Eli Lilly and Company with Chinese NMPA approval number HJ20240023 and product code 86978396000310.
Mounjaro Tirzepatide Product Specifications
| Parameter | Details |
|---|---|
| Product Name | Tirzepatide Injection Mounjaro |
| Generic Name | Tirzepatide |
| CAS Number | 2023788-19-2 |
| Molecular Formula | C225H348N48O68 |
| Molecular Weight | ~4813.5 g/mol |
| Dosage Form | Injection (pre-filled pen) |
| Strength | 5mg / 0.5ml per pen |
| Quantity | 4 pens per box |
| Approval Number | HJ20240023 (China NMPA) |
| Product Code | 86978396000310 |
| Manufacturer | Eli Lilly and Company |
| Barcode | (Unavailable or pending update) |
| Intended Use | Laboratory research only |
| Storage Conditions | Store refrigerated at 2–8°C; do not freeze |
Mounjaro Tirzepatide Mechanism of Action & Research Applications
Tirzepatide is a dual incretin receptor agonist, acting on both GIP and GLP-1 receptors, which enhances glucose-dependent insulin secretion, delays gastric emptying, and promotes appetite suppression.
Research Applications Include:
Type 2 diabetes and glucose metabolism models
Obesity and weight loss efficacy studies
GLP-1/GIP receptor signal pathway research
Combination therapy with insulin or metformin
Incretin biology and metabolic syndrome exploration
Mounjaro Tirzepatide Possible Side Effects (Observed in Research Studies)
Gastrointestinal effects (nausea, vomiting)
Appetite suppression and weight loss
Delayed gastric emptying
Mild injection site reactions
Potential hypoglycemia in combination with insulin
Safety & Handling Instructions
Use Restriction: For laboratory research only.
Protective Measures: Use gloves, lab coat, and eye protection.
Storage: Store refrigerated (2–8°C). Do not freeze. Protect from light.
Disposal: Dispose of used pens and components per institutional guidelines.
Mounjaro Tirzepatide Research Use Disclaimer
This product is intended exclusively for laboratory research. It is not approved for therapeutic, diagnostic, or veterinary use. Misuse may pose serious safety risks. Always follow local regulations and institutional safety protocols.
Additional information
| Weight | 1 kg |
|---|---|
| Dimensions | 36 × 32 × 36 cm |
1 review for Mounjaro Tirzepatide Injection wholesale – supplier (manufacturer)
Q1: Is this tirzepatide product for human or clinical use?
A1: No. This product is strictly for laboratory research purposes only.
Q2: Can I buy in large quantities for institutional use?
A2: Yes. Both wholesale and retail are supported. Contact us for bulk pricing.
Q3: What makes tirzepatide different from GLP-1 agonists like semaglutide?
A3: Tirzepatide is a dual GIP and GLP-1 agonist, potentially offering superior glycemic and weight loss effects in research models.
Q4: Is this the same formulation as Mounjaro?
A4: Yes, Mufengda is a branded version equivalent to Mounjaro, for research reference only.
Q5: Do you provide COA or SDS documents?
A5: Yes. Certificates of Analysis and Safety Data Sheets are available upon request.
Q6: What type of injection device is used?
A6: The product comes in pre-filled pens, each containing 0.5ml of 5mg tirzepatide.
Q7: Can this product be used in GLP-1 receptor antagonist research?
A7: Yes. It is suitable for agonist-antagonist interaction studies and receptor specificity testing.
Q8: Is cold chain shipping supported?
A8: Yes. Cold chain logistics are available to ensure product stability during transit.
Q9: How does tirzepatide affect weight loss in animal models?
A9: Studies show significant appetite reduction and fat mass decrease, making it valuable in obesity research.
Q10: What organisms is this product compatible with?
A10: It is commonly used in mouse, rat, and primate models for metabolic studies.
Related products
Epalrestat Tablets 50mg – For Laboratory Research Use Only
Epalrestat Tablets provide 50mg of active compound per tablet. Manufactured by Hebei Ruisen Pharmaceutical Co., Ltd. Approved under H20253680. Intended strictly for laboratory research use only. Supports both bulk and individual orders.?For wholesale prices, other specifications and uses, please consult our staff?
$2.00Semaglutide Tablets
Rybelsus® oral semaglutide — 7mg film-coated tablets, 10 per box, produced by Novo Nordisk A/S. The first FDA- and EMA-approved oral GLP-1 receptor agonist for type 2 diabetes. Ideal for metabolic, weight loss, and endocrinology research. $1.00Voglibose Tablets (Litanging) 0.2mg – Factory low price wholesale
Litanging Voglibose Tablets contain 0.2mg of voglibose per tablet, supplied in 60-tablet boxes. Produced by Shijiazhuang Huaxin Pharmaceutical Co., Ltd. NMPA-approved under H20163123. Intended for experimental/laboratory use only.?For wholesale prices, other specifications and uses, please consult our staff?
$3.00Vildagliptin Tablets
Weitangning Vildagliptin 50mg tablets offer a reliable research-grade option for investigation into incretin-based antidiabetic mechanisms. With credible manufacturer credentials, NMPA approval, and stable packaging, this product adds great value to labs and research institutions.
$1.00
Reminder: Not for human use—lab use only.
moodl –
It is authentic, the package was received quickly, thank you